Research location
Yenimahalle
Ankara, Turkey (Türkiye)
Advertisement
Research activity in Yenimahalle
Ankara, Turkey (Türkiye)CureCurrent currently publishes aggregate city-level research activity for this location: 12 trials and 13 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Yenimahalle
12 linked trials · page 1 of 1Comparison of Conventional and Retroclavicular Approaches for Ultrasound-guided Infraclavicular Brachial Plexus BlockNCT07151443 · 2025-09-15 · 1 site observation
RECRUITING
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)NCT06312176 · 2024-04-14 · 1 site observation
RECRUITING
Different Intraperitoneal Pressures on Optic Nerve Sheath Diameter in Laparoscopic SurgeriesNCT07155109 · 2025-08-30 · 1 site observation
NOT_YET_RECRUITING
Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)NCT06430866 · 2024-09-12 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung CancerNCT06311721 · 2024-09-09 · 1 site observation
ACTIVE_NOT_RECRUITING
Effects of Aerobic Exercise on Cancer-Related Biomarkers, Functional Capacity, Cognitive Status and Quality of Life in Women With Breast CancerNCT06540612 · 2024-05-15 · 1 site observation
COMPLETED
Comparison of Erector Spinae Plane Block and Serratus Posterior Superior Intercostal Plane BlockNCT06407037 · 2023-12-27 · 1 site observation
COMPLETED
A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3)NCT06140836 · 2023-12-21 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's SyndromeNCT05946941 · 2023-09-11 · 1 site observation
ACTIVE_NOT_RECRUITING
Relationship of Nutritional Status to Chemotherapy Treatment Completion and Outcomes in Cancer PatientsNCT07059598 · 2022-08-12 · 2 site observations
COMPLETED
Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)NCT04152499 · 2020-02-28 · 1 site observation
ACTIVE_NOT_RECRUITING
International Registry of Congenital Portosystemic Shunt (IRCPSS)NCT06041906 · 2018-04-26 · 1 site observation
ENROLLING_BY_INVITATION
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.